Davis Rea Ltd. Johnson & Johnson Transaction History

Davis Rea Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 25, 2022	SELL	$155.93 - $173.01 $322,151 - $357,438	-2,066 Closed	0 $0
Q3 2021 Oct 25, 2021	SELL	$161.5 - $179.47 $96,900 - $107,682	-600 Reduced 22.51%	2,066 $334,000
Q2 2021 Jul 14, 2021	BUY	$159.48 - $171.07 $9,568 - $10,264	60 Added 2.3%	2,666 $439,000
Q1 2021 May 03, 2021	SELL	$153.07 - $170.48 $9,031 - $10,058	-59 Reduced 2.21%	2,606 $428,000
Q4 2020 Jan 15, 2021	BUY	$137.11 - $157.38 $29,752 - $34,151	217 Added 8.86%	2,665 $419,000
Q2 2020 Jul 20, 2020	BUY	$128.81 - $155.51 $25,504 - $30,790	198 Added 8.8%	2,448 $344,000
Q3 2019 Oct 29, 2019	SELL	$126.95 - $142.14 $81,248 - $90,969	-640 Reduced 22.15%	2,250 $291,000
Q1 2018 Apr 06, 2018	SELL	$125.1 - $148.14 $212,670 - $251,837	-1,700 Reduced 37.04%	2,890 $370,000
Q4 2017 Feb 08, 2018	SELL	$131.22 - $143.62 $26,244 - $28,724	-200 Reduced 4.18%	4,590 $641,000
Q3 2017 Nov 08, 2017	BUY	$129.47 - $135.38 $620,161 - $648,470	4,790	4,790 $623,000

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $421B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Davis Rea Ltd., based on Form 13F filings with the SEC.

Stay updated on Davis Rea Ltd. with notifications on news.